| Financial Year |
March 31 2023 |
| Monetary Funds |
5,853,929,091.02 |
| Held-for-trading Financial Assets |
250,802,870.28 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,885,992,283.98 |
| Advances to Suppliers |
45,024,757.74 |
| Other Receivables |
97,372,570.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,448,841,210.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
270,422,555.56 |
| Other Current Assets |
166,239,145.08 |
| Total Current Assets |
12,590,478,566.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
98,569,119.93 |
| Investment Properties |
52,403,667.58 |
| Fixed Assetes |
2,192,388,880.83 |
| Under-construction Projects |
80,533,557.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
933,580,214.84 |
| R&D expenses |
73,347,089.12 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,390,674.26 |
| Deferred Income Tax Assets |
157,032,303.12 |
| Other Non-Current Assets |
2,411,486.64 |
| Sub-Total of Non-Current Assets |
4,470,657,567.14 |
| Total Assets |
17,061,136,133.84 |
| Short-Term Loans |
488,328,290.84 |
| Trading Financial liabilities |
33,521,920.35 |
| Notes Payable |
4,681,667,908.72 |
| Accounts Payable |
4,027,615,277.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
317,581,219.13 |
| Taxes Payable |
76,006,534.88 |
| Interest Payable |
-- |
| Dividend Payable |
4,978,994.16 |
| Other payables |
901,277,527.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,702,488.42 |
| Other Current Liabilities |
29,608,735.19 |
| Sub-Total of Current Liabilities |
10,999,824,708.82 |
| Long-term Loans |
148,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,097,197.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
32,851,482.36 |
| Deferred Income Tax Liabilities |
16,171,532.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
387,985,024.74 |
| Total Liabilities |
11,387,809,733.56 |
| Paid-In Capital(Or Share Stock) |
1,029,923,715.00 |
| Capital Surplus |
2,806,493,904.30 |
| Surplus Reserve |
441,218,691.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,031,789,716.89 |
| Minority Stockholder's Interest |
377,040,228.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,296,286,171.68 |
| Owner's Equity（Stockholder's Equity） |
5,673,326,400.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,061,136,133.84 |
